<DOC>
	<DOCNO>NCT01568268</DOCNO>
	<brief_summary>This study design evaluate treatment efficacy safety palonosetron patient undergo laparoscopic gynecologic , abdominal surgery general anesthesia .</brief_summary>
	<brief_title>Therapeutic Efficacy Safety Palonosetron Treatment Postoperative Nausea Vomiting</brief_title>
	<detailed_description>Postoperative nausea vomiting ( PONV ) frequent complication surgery , produce subject discomfort medical economic consequence . This study design evaluate treatment efficacy safety palonosetron subject undergo gynecologic simple laparoscopic surgery . As previous study palonosetron evaluate prevention postoperative nausea vomiting ( PONV ) , evidence-based guideline palonosetron treatment PONV . The aim present study evaluate treatment efficacy safety palonosetron patient undergo laparoscopic gynecologic , abdominal surgery general anesthesia .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>19 year old , young 70 year old American society Anesthesiologists physical status classification I III undergo laparoscopic gynecologic , abdominal surgery general anesthesia surgery anesthesia expect last least 30 minute subject may develop prolongation cardiac conduction interval , particularly correct QT interval , he/she may enrol discretion investigator . know hypersensitivity/ contraindication 5hydroxytryptamine antagonist study drug excipient inability understand cooperate study procedure determine investigator woman pregnant , nurse plan become pregnant , use effective birth control , positive serum pregnancy test within 7 day prior surgery day 1. receive investigational drug within 30 day study entry take drug potential antiemetic efficacy within 24 hour prior anesthetic procedure . vomit , retch , nausea 24 hour precede administration anesthesia know suspected current history alcohol abuse drug abuse . condition , opinion investigator would make subject ineligible participation study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>palonosetron</keyword>
	<keyword>postoperative nausea vomit</keyword>
</DOC>